Food-drug interactions of novel drugs used in cardiologic and diabetic patients - a PRISMA scoping review. [PDF]
Pawłowska I +4 more
europepmc +1 more source
Influence of Lipid Matrix Composition on the Intestinal Permeation of Curcumin-Loaded Lipid Nanoparticles. [PDF]
Khan AS, Müller D, Keck CM.
europepmc +1 more source
Lipid Nanoparticle Delivery of CAR276 mRNA Enables Antigen-Specific Cytotoxicity in T Cells Against Glioblastoma Cells. [PDF]
Zahedipour F +9 more
europepmc +1 more source
Refining Bioequivalence Assessment of Topical Drug Products for Local Action: A Comparative Analysis of Tape Stripping Methodologies. [PDF]
Rath S, Kanfer I.
europepmc +1 more source
Expression of concern: Flavin-adenine-dinucleotide gold complex nanoparticles: chemical modeling design, physico-chemical assessment and perspectives in nanomedicine. [PDF]
Arib C +6 more
europepmc +1 more source
Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025. [PDF]
Cordes H +35 more
europepmc +1 more source
Six Years of Progress in the Oral Biopharmaceutics Area – A Summary From the IMI OrBiTo Project [PDF]
OrBiTo was a precompetitive collaboration focused on the development of the next generation of Oral Biopharmaceutics Tools. The consortium included world leading scientists from nine universities, one regulatory agency, one non-profit research ...
Anette Müllertz +2 more
exaly +2 more sources
The objective was using the Essential Medicines List for children by the World Health Organization (WHO) to create a pediatric biopharmaceutics classification system (pBCS) of the oral drugs included in the Essential Medicines List by the World Health ...
Marival Bermejo +2 more
exaly +3 more sources
Towards the Development of a Paediatric Biopharmaceutics Classification System: Results of a Survey of Experts [PDF]
The aim of this research survey was to understand current global thinking around the need for and development of a paediatric biopharmaceutics classification system (pBCS) to be used for the development of paediatric medicines and regulatory purposes (e ...
Sandra Klein +2 more
exaly +5 more sources

